An analysis of human colon cancer samples data from The Cancer Genome Atlas (TCGA) showed that higher GATA4 expression correlated with shorter survival in male patients with colon adenocarcinoma (p = 0.0054), though no such correlation was detected in females (p = 0.27; Figure 6(d)). Here, GATA4 is linked to colonic neoplasm.